Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
0.339
-0.011 (-3.17%)
At close: Nov 20, 2024, 4:00 PM
0.331
-0.008 (-2.33%)
Pre-market: Nov 21, 2024, 4:55 AM EST
Aditxt Employees
Aditxt had 47 employees as of December 31, 2023. The number of employees decreased by 14 or -22.95% compared to the previous year.
Employees
47
Change (1Y)
-14
Growth (1Y)
-22.95%
Revenue / Employee
$4,513
Profits / Employee
-$867,255
Market Cap
2.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Regional Health Properties | 114 |
iSpecimen | 53 |
Matinas BioPharma Holdings | 32 |
Oncternal Therapeutics | 30 |
Theriva Biologics | 22 |
Processa Pharmaceuticals | 13 |
Bio-Path Holdings | 10 |
Palisade Bio | 9 |
ADTX News
- 6 days ago - Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PRNewsWire
- 12 days ago - Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares - Business Wire
- 13 days ago - Aditxt's Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders - Business Wire
- 14 days ago - Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem - Business Wire
- 14 days ago - Evofem Secures Investor Support for Proposed Merger through Voting Agreements - PRNewsWire
- 20 days ago - Aditxt's Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission - Business Wire
- 21 days ago - Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time - Business Wire
- 22 days ago - Sylvia Hermina Joins Aditxt's Board of Directors, Elevating Leadership with Broader Perspectives - Business Wire